OncoNano Medicine is developing a new class of pH-activated compounds that digitalize and exploit the variability of pH in disease. pH variability is a proven, simple, and effective identifier of diseased tissue providing a foundation for the development of a broad range of highly targeted therapeutics and imaging agents.

Biotechnology

OncoNano Medicine

Kathy Rath

Matthew Head

Angie Haar

Tian Zhao

Kartik Krishnan

Ruolan Han

Bhargavi Allu

Leadership Team

Regulatory and Compliance Team

Finance and Operations Team

Research and Development Team

Teams at OncoNano Medicine

Leadership Team

Regulatory and Compliance Team

Finance and Operations Team

Research and Development Team